1,341
Views
14
CrossRef citations to date
0
Altmetric
Research Paper

Methylome sequencing for fibrolamellar hepatocellular carcinoma depicts distinctive features

, , , , , , , , , , , , , & show all
Pages 872-881 | Received 04 May 2015, Accepted 20 Jul 2015, Published online: 26 Aug 2015

References

  • Torbenson M. Fibrolamellar Carcinoma: 2012 Update. Scientifica 2012; 2012:743790; PMID:24278737
  • Edmondson HA. Differential diagnosis of tumors and tumor-like lesions of the liver in infancy and childhood. AMA J Dis Child 1956; 91(2):168-86
  • Malouf G, Falissard B, Azoulay D, Callea F, Ferrell LD, Goodman ZD, Hayashi Y, Hsu HC, Hubscher SG, Kojiro M, et al. Is histological diagnosis of primary liver carcinomas with fibrous stroma reproducible among experts? J Clin Pathol 2009; 62:519-524; PMID:19155239; http://dx.doi.org/10.1136/jcp.2008.062620
  • Malouf GG, Brugieres L, Le Deley MC, Faivre S, Fabre M, Paradis V, Aerts I, Le Tourneau C, Dreyer C, Branchereau S, et al. Pure and mixed fibrolamellar hepatocellular carcinomas differ in natural history and prognosis after complete surgical resection. Cancer 2012; 118:4981-90; PMID:22415897; http://dx.doi.org/10.1002/cncr.27520
  • Cornella H, Alsinet C, Sayols S, Zhang Z, Hao K, Cabellos L, Hoshida Y, Villanueva A, Thung S, Ward SC, et al. Unique genomic profile of fibrolamellar hepatocellular carcinoma. 2013 2015, 148:806-818 e810; PMID:25557953
  • Malouf GG, Job S, Paradis V, Fabre M, Brugieres L, Saintigny P, Vescovo L, Belghiti J, Branchereau S, Faivre S, et al. Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature. Hepatology 2014; 59:2228-37; PMID:24443104; http://dx.doi.org/10.1002/hep.27018
  • Xu L, Hazard FK, Zmoos AF, Jahchan N, Chaib H, Garfin PM, Rangaswami A, Snyder MP, Sage J. Genomic analysis of fibrolamellar hepatocellular carcinoma. Hum Mol Genet 2014, 24:50-63; PMID:25122662; http://dx.doi.org/10.1093/hmg/ddu418
  • Honeyman JN, Simon EP, Robine N, Chiaroni-Clarke R, Darcy DG, Lim, II, Gleason CE, Murphy JM, Rosenberg BR, Teegan L, et al. Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma. Science 2014; 343(6174):1010-4; PMID:24578576
  • Graham RP, Jin L, Knutson DL, Kloft-Nelson SM, Greipp PT, Waldburger N, Roessler S, Longerich T, Roberts LR, Oliveira AM, et al. DNAJB1-PRKACA is specific for fibrolamellar carcinoma. Mod Pathol 2015; 28(6):822-9; PMID:25698061
  • Ziller MJ, Gu H, Muller F, Donaghey J, Tsai LT, Kohlbacher O, De Jager PL, Rosen ED, Bennett DA, Bernstein BE, et al. Charting a dynamic DNA methylation landscape of the human genome. Nature 2013, 500:477-481; PMID:23925113; http://dx.doi.org/10.1038/nature12433
  • Sirivatanauksorn Y, Sirivatanauksorn V, Lemoine NR, Williamson RC, Davidson BR. Genomic homogeneity in fibrolamellar carcinomas. Gut 2001, 49:82-86; PMID:11413114; http://dx.doi.org/10.1136/gut.49.1.82
  • Trankenschuh W, Puls F, Christgen M, Albat C, Heim A, Poczkaj J, Fleming P, Kreipe H, Lehmann U. Frequent and distinct aberrations of DNA methylation patterns in fibrolamellar carcinoma of the liver. PLoS One 2010, 5:e13688; PMID:21060828; http://dx.doi.org/10.1371/journal.pone.0013688
  • Vivekanandan P, Torbenson M. Epigenetic instability is rare in fibrolamellar carcinomas but common in viral-associated hepatocellular carcinomas. Mod Pathol 2008, 21:670-675; PMID:18264082; http://dx.doi.org/10.1038/modpathol.2008.32
  • Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009, 462:315-22; PMID:19829295; http://dx.doi.org/10.1038/nature08514
  • Hansen KD, Timp W, Bravo HC, Sabunciyan S, Langmead B, McDonald OG, Wen B, Wu H, Liu Y, Diep D, et al. Increased methylation variation in epigenetic domains across cancer types. Nat Genet 2011, 43:768-75; PMID:21706001; http://dx.doi.org/10.1038/ng.865
  • Malouf GG, Brugières L, Ledeley MC, Faivre S, Fabre M, Paradis V, Aerts I, Le Tourneau C, Dreyer C, Branchereau S, et al. Pure and Mixed Fibrolamellar Hepatocellular Carcinomas Differ in Natural History and Prognosis after Complete Surgical Resection. Cancer 2012; 118(20):4981-90.
  • Jelinek J, Liang S, Lu Y, He R, Ramagli LS, Shpall EJ, Estecio MR, Issa JP. Conserved DNA methylation patterns in healthy blood cells and extensive changes in leukemia measured by a new quantitative technique. Epigenetics 2012, 7:1368-78; PMID:23075513; http://dx.doi.org/10.4161/epi.22552
  • Figueiredo JC, Grau MV, Wallace K, Levine AJ, Shen L, Hamdan R, Chen X, Bresalier RS, McKeown-Eyssen G, Haile RW, et al. Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. Cancer Epidemiol Biomarkers Prev 2009, 18:1041-9; PMID:19336559; http://dx.doi.org/10.1158/1055-9965.EPI-08-0926
  • Colella S, Shen L, Baggerly KA, Issa JP, Krahe R. Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. Biotechniques 2003, 35:146-50; PMID:12866414
  • Hammarsund M, Corcoran MM, Wilson W, Zhu C, Einhorn S, Sangfelt O, Grander D. Characterization of a novel B-CLL candidate gene-DLEU7-located in the 13q14 tumor suppressor locus. FEBS Lett 2004, 556:75-80; PMID:14706829; http://dx.doi.org/10.1016/S0014-5793(03)01371-1
  • Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4(1):44-57; PMID:19131956.
  • Zhao M, Sun J, Zhao Z. TSGene: a web resource for tumor suppressor genes. Nucleic Acids Res 2013, 41:D970-976; PMID:23066107; http://dx.doi.org/10.1093/nar/gks937
  • McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, Wenger AM, Bejerano G. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol 2010, 28:495-501; PMID:20436461; http://dx.doi.org/10.1038/nbt.1630
  • Easwaran H, Johnstone SE, Van Neste L, Ohm J, Mosbruger T, Wang Q, Aryee MJ, Joyce P, Ahuja N, Weisenberger D, et al. A DNA hypermethylation module for the stem/progenitor cell signature of cancer. Genome Res 2012, 22:837-49; PMID:22391556; http://dx.doi.org/10.1101/gr.131169.111

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.